Drug Trial News

RSS

Tamoxifen reduces long-term risk of cancer

According to a new study released this week, women at high risk for breast cancer who take the well-known drug Tamoxifen, can reduce their long-term risk of developing the disease.

16 Nov 2005

Lack of aggressive treatment for clogged leg blood vessels means missed heart attack prevention opportunity

Despite the fact that clogged arteries in the legs usually mean clogged arteries near the heart, doctors often fail to give heart-protecting drugs to people with severe leg blood vessel blockages, a new University of Michigan-led study finds.

15 Nov 2005

Genetic makeup helps dictate how physically and mentally healthy you feel

You can blame your parents for your hair that frizzes in high humidity and for your short stature. And now researchers at Saint Louis University School of Public Health say your genetic makeup partly dictates how physically and mentally healthy you feel.

15 Nov 2005

Study suggests that some patients on beta blockers should not be

A Johns Hopkins study has raised doubts about a long-accepted notion of what's going on in many cases of heart failure, suggesting that nearly half of patients with the disorder may be getting the wrong treatment for their disease.

15 Nov 2005

It's true! study confirms that Glucosamine and Chondroitin relieve arthritis pain

The millions of Osteoarthritis sufferers in the world will welcome the good news that a new study has confirmed that the dietary supplements glucosamine and chondroitin provide pain relief.

15 Nov 2005

Clinical decision support system reduces overall use of antimicrobials for colds, bronchitis and sinusitis

A clinical decision support system intervention reduced the overall use of antimicrobials for respiratory tract infections such as colds, bronchitis and sinusitis, according to a study in the JAMA: The Journal of the American Medical Association.

15 Nov 2005

Gene therapy and exercise may help sufferers of Lou Gehrig's disease

A new study in mice gives hope that a combination of gene therapy and exercise may extend the lives of people who have Lou Gehrig's disease.

15 Nov 2005

Blood pressure near the heart is more predictive of cardiovascular outcomes than blood pressure measured in the arm

Results from a new study show that amlodipine-based (calcium channel blocker) treatment is much more effective at reducing blood pressure near the heart than a conventional atenolol-based (beta blocker) regimen.

14 Nov 2005

Largest hepatitis-C U.S. study defines optimal therapy

Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.

14 Nov 2005

Norvasc better than beta blockers for lowering blood pressure

According to a study presented at a meeting of the American Heart Association, Norvasc, was more effective at reducing blood pressure near the heart than standard, older treatments such as beta blockers.

14 Nov 2005

Edifoligide no better than placebo for clogged veins

A new drug, edifoligide, designed to prevent the clogging of veins used in coronary bypass surgery was no more effective than a placebo, according to the results of a Phase III clinical trial led by researchers at Duke Clinical Research Institute (DCRI).

14 Nov 2005

Race may play a role in whether a patient accepts surgical treatment for lung cancer

A study in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), found that blacks with lung cancer declined surgery at a higher rate than whites

14 Nov 2005

Early changes in the oxygenation of the skin may help predict foot disease in diabetes patients

Foot ulcerations are one of the most serious complications of diabetes, resulting in more than 80,000 lower-leg amputations each year in the U.S. alone.

14 Nov 2005

$230 billion in health care spending nationally is devoted to insurance administration

Billing and insurance paperwork consume at least one out of every five dollars of private insurance health spending in California, according to a new study by health policy researchers.

14 Nov 2005

Australian study highlights lateral genetic transfer

A University of Queensland study mapping the evolution of genes has shed light on the role of gene transfer in bacterial diseases.

14 Nov 2005

Meditation may slow down brain aging

The regular practice of meditation appears to produce structural changes in areas of the brain associated with attention and sensory processing.

14 Nov 2005

New respiratory synctial virus treatment for at-risk infants under study

A new, enhanced-potency onoclonal antibody designed to keep the sniffles from turning into a devasting illness in at-risk babies is under study at the Medical College of Georgia Children's Medical Center.

14 Nov 2005

Speed of PSA increase matters more than PSA level

In the largest study of its kind to date, Mayo Clinic researchers report that prostate specific antigen (PSA) kinetics, both velocity and doubling time, can be used to predict disease progression and likelihood of death after radical prostatectomy surgery, suggesting that this could be used to guide treatment decisions.

14 Nov 2005

Role of statin therapy in patients with heart failure

An advanced study launched at Yale School of Medicine is evaluating the role of statin therapy in patients with heart failure, one of the leading causes of hospitalization in people over age 65.

14 Nov 2005

Study suggests that subtle breakdowns in attention may offer a reliable clue to Alzheimer's-related dementia

People in early stages of Alzheimer's disease have greater difficulty shifting attention back and forth between competing sources of information, a finding that offers new support for theories that contend breakdowns in attention play an important role in the onset of the disease.

14 Nov 2005

Drug Trial News

Tamoxifen reduces long-term risk of cancer

Lack of aggressive treatment for clogged leg blood vessels means missed heart attack prevention opportunity

Genetic makeup helps dictate how physically and mentally healthy you feel

Study suggests that some patients on beta blockers should not be

It's true! study confirms that Glucosamine and Chondroitin relieve arthritis pain

Clinical decision support system reduces overall use of antimicrobials for colds, bronchitis and sinusitis

Gene therapy and exercise may help sufferers of Lou Gehrig's disease

Blood pressure near the heart is more predictive of cardiovascular outcomes than blood pressure measured in the arm

Largest hepatitis-C U.S. study defines optimal therapy

Norvasc better than beta blockers for lowering blood pressure

Edifoligide no better than placebo for clogged veins

Race may play a role in whether a patient accepts surgical treatment for lung cancer

Early changes in the oxygenation of the skin may help predict foot disease in diabetes patients

$230 billion in health care spending nationally is devoted to insurance administration

Australian study highlights lateral genetic transfer

Meditation may slow down brain aging

New respiratory synctial virus treatment for at-risk infants under study

Speed of PSA increase matters more than PSA level

Role of statin therapy in patients with heart failure

Study suggests that subtle breakdowns in attention may offer a reliable clue to Alzheimer's-related dementia

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News